Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10965917 | Vaccine | 2014 | 9 Pages |
Abstract
Two-dose HPV vaccination is likely to be cost-effective if its duration of protection is at least 10 years. A third dose of HPV vaccine is unlikely to be cost-effective if two-dose duration of protection is longer than 30 years. Finally, two-dose girls & boys HPV vaccination is unlikely to be cost-effective unless the cost per dose for boys is substantially lower than the cost for girls.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jean-François Laprise, Mélanie Drolet, Marie-Claude Boily, Mark Jit, Chantal Sauvageau, Eduardo L. Franco, Philippe Lemieux-Mellouki, TalÃa Malagón, Marc Brisson,